Tri Locum Partners LP Reata Pharmaceuticals Inc Transaction History

Tri Locum Partners LP

  • $374 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$79.22 - $105.37 $2.3 Million - $3.06 Million
29,068 Added 43.25%
96,274 $9.82 Million
Q1 2023

May 15, 2023
SELL
$30.85 - $93.17 $2.29 Million - $6.92 Million
-74,260 Reduced 52.49%
67,206 $6.11 Million
Q4 2022

Feb 14, 2023
BUY
$22.15 - $42.11 $3.13 Million - $5.96 Million
141,466 New
141,466 $5.37 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Tri Locum Partners LP Portfolio

Follow Tri Locum Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Tri Locum Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email